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Summary After the transfer of spleen cells from old CBA/T6T6 mice (>75 weeks) into young syngeneic
CBA/Ca recipients there usually follows a selective expansion of the donor T-cell population and the
emergence of type B reticulum cell neoplasms (RCN-B), also of donor origin though probably derived not
from the T-cells but from lymphoid dendritic accessory cells. As few as one million injected cells led to
significant donor T-cell hyperplasia and tumour induction. Injection of cells from young donors did not have
such consequences. Similar tumours were induced by transferring syngeneic cells in both C57BL and DBA/2
mice, although in the latter strain there was no requirement for the injected cells to derive from old donors.
It appeared that T-cell proliferation was independent of donor accessory cells or RCN-B induction, since
injection of enriched T-cells led to few tumours, although the T-cell chimaerism was indistinguishable from
that in recipients of unseparated spleen cells. Development of tumours, however, seemed to be dependent
upon stimulated T-cells. Recipients of spleen cells from old T-cell-deprived mice did not develop tumours;
conversely, tumours, mostly of donor origin, were induced in recipients of young syngeneic cells when an
extrinsic stimulus to T-cell proliferation was provided by continued allostimulation.
The apparent selectivity of tumorigenesis for donor cells has led to the proposal that cellular relocation, as
a result of transfer, may be an important predisposing factor in malignant transformation in circumstances of
T-cell stimulation provided by antigenic challenge or by transfer of T-cells from old donors.
In a previous paper (Wallis et al., 1984), it was shown that
injection of spleen cells from individual old mice of the
CBA/T6T6 strain into syngeneic young adult CBA/Ca
recipients usually had two unexpected consequences. Firstly,
in most recipients there developed a selective proliferation of
T lymphocytes of donor origin, manifest as an increase in
the percent chimaerism ascertained from phytohaem-
agglutinin(PHA)-stimulated samples of peripheral blood
lymphocytes; secondly, a high proportion of the mice
developed tumours, which were histologically classifiable as
reticulum cell neoplasms, type B (RCN-B) (Dunn &
Deringer, 1968). These tumours were nearly all of donor
origin because they carried the chromosomal marker of the
donor cells. The predominant tumour cell type proved to be
transplantable and to have several characteristics of the
lymphoid dendritic class of accessory cells described by
Steinman and Nussenzweig in 1980 (Brittle et al., 1985a, b).
In the present paper the results of a longitudinal
examination of relatively large groups of recipients of cells
from syngeneic old mice are presented. While these
confirmed our previous observations that donor T-cell
proliferation and donor cell neoplasia usually occur
following injection, there was no clear correlation between
the two. Attempts have therefore been made to define their
requirements by transfers of separated cell populations. In
addition, the phenomenon of tumour induction has been
investigated in two further strains of mice, namely C57BL
and DBA/2.
Materials and methods
Mice
Male mice of the CBA/Ca, CBA/T6T6 and C57BL/Cbi
strains and (CBA x C57BL)F1 hybrids were used. Female
mice of the DBA/2 strain were used. In nearly all of the
experiments reported here CBA/Ca strain young adult (12-
16 week) hosts received spleen cells i.v. from mice of the
syngeneic CBA/T6T6 strain which bear a pair of marker
chromosomes. The donors were either the same age as the
young adult recipients or much older, i.e., more than 75
weeks old. In one experiment, aged T-cell-deprived donor
mice were used: these animals had been thymectomised at 8
weeks of age and irradiated 2 weeks later with 850r and
reconstituted with 5 x 106 syngeneic bone-marrow cells.
Young adult C57BL/Cbi and DBA/2 mice were used
similarly as recipients of syngeneic spleen cells from young
or old donors (C57BL: 70 weeks; DBA/2: 109-113 weeks).
In some experiments, CBA mice were given repeated
alloantigenic challenge with the intention of stimulating
profound T-cell proliferation. This was performed by i.v.
injection of 10 x 106 (C57BL x CBA/Ca)F1 spleen cells every
2 weeks, thereby inducing a host versus graft (P anti-F1)
response.
Preparation ofcell suspensions
Cell suspensions were prepared by pressing spleens through a
fine sieve followed by gentle pipetting. Suspended cells were
washed twice in TC199 before injection. Cells for culture
were similarly treated but were washed only once before
resuspending in culture medium. Cells to be enriched by
buoyant density separation were further treated with Gey's
solution to remove red cells.
Preparation oflow densityspleen cells
Isopycnic centrifugation of spleen cells on discontinuous
bovine serum albumen (BSA) density gradients was
performed by the method of Raidt et al. (1968). Step
gradients containing 33% and 23% BSA (Pentex Path 0
Cyte, Miles Laboratories Ltd.), to which inocula of 50 x 106
spleen cells had been added, were centrifuged at 10,OOOg for
40min at 4°C. Low density cells were removed from above
the 23% layer. The mean yield of low density cells was
9+2% of the starting populations. These were expected to
contain the lymphoid dendritic accessory cells (Steinman &
Nussenzweig, 1980) and to be -11 times (100/9) richer than
unseparated spleen cells.
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Preparation ofnylon wool non-adherent cells (T-cells)
T-cells were enriched from the spleens of normal mice by the
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method of Julius et al. (1973). Spleen cells in RPMI
containing 10% FCS were incubated on nylon wool columns
at the ratio of 108 cells per 400mg wool (Fenwal Leuco-Pak
wool, Travenol Laboratories Ltd.) for 1 h at 37°C. After
incubation, cells were eluted from the column by washing
with RPMI medium until cells were no longer apparent in
the effluent. The mean yield of the T-cells prepared in this
way was 24% of the starting spleen white cells. The
proportion of Thy 1.2 positive cells was enriched from 29%
to a mean of 84%: these are functionally depleted with
respect to accessory cells necessary for in vitro T-cell
mitogenesis (Brittle et al., 1985b).
Cultures
Samples of peripheral blood of -0.3ml were removed from
the retro-orbital sinus of experimental mice and, after
defribination with glass beads, they were sedimented in
plasmagel as described previously (Doenhoff et al., 1970).
The separated lymphocytes were cultured at 2 x 106 cells per
ml with PHA at 2.5ygmlI- in RPMI 1640 containing 10%
foetal calf serum (FCS) (Gibco Ltd.), 4mM glutamine and
10-4M 2-mercaptoethanol. The cultures were incubated in
10% 02, 86% N2 and 4% CO2 at 37°C. After 42-45h
culture, colcemid (CIBA Ltd.) at 0.l jygml- was added to
arrest dividing cells at metaphase. Four hours later the
cultures were harvested.
Chromosome preparations
The method of preparation of chromosome spreads was
basically that of Ford (1966). Briefly, after a short
incubation in hypotonic trisodium citrate (1% w/v) the cells
were fixed in three changes of acetic alcohol. Two slides of
each specimen were prepared by air drying, stained in
Giemsa (15%) and mounted in euparal. One hundred cells
on each slide were scored to determine the relative pro-
portions of cells of CBA/Ca (host) and CBA/T6T6 (donor)
origin. For the determination of the origin of transplantable
tumours, tumour-bearing mice were injected with colcemid
(4jgg-1 body wt) 1.25 h before killing. Chromosome
preparations were then made from tumour cell suspensions
using the methods referred to above.
Cellphenotyping
Suspensions of transplanted tumours were depleted of
adherent cells by incubating on plastic for 2h. They were
examined for surface markers by standard methods of
indirect immunofluorescence as previously described (Brittle
et al., 1985a). Briefly, a polyspecific rabbit anti-mouse
immunoglobulin antiserum (Miles Ltd.), which was
fluoresceinated at a fluorochrome:protein ratio of 2:1, was
used to detect surface Ig-positive cells. To detect class II
products, aliquots of cells at 2 x 106 per ml were incubated
on ice for 30min with appropriate dilutions of anti-Iak
(A.TH anti A.TL) alloantiserum or anti-I-Ak monoclonal
antibody (M.Ab) (Ia2 clone 14V18) supplied by Cedar Lane
Labs., Ontario. Following washing, cells were further
incubated in the fluoresceinated rabbit anti-mouse Ig, before
being washed again and examined by fluorescence
microscopy. As controls, cells were treated with the
fluoresceinated anti-Ig reagent alone. Staining for surface
Thyl.2 was performed using biotinylated anti-Thyl.2 M.Ab
(Becton clone 30H12) Becton-Dickinson, Mechelen, in
combination with a second layer of fluoresceinated avidin,
again employing the conditions of incubation described
above.
Experimental design
Mice were monitored longitudinally to assess the level of
donor T-cell chimaerism. Each individual was bled 4 weeks
after injection and thereafter at 4-8 week intervals, and their
peripheral blood lymphocytes cultured as described above.
This meant that most animals were bled 10-15 times in their
life. For the purpose of comparing chimaerism between
individuals, a mean percentage was calculated from all of the
values recorded for each mouse over the entire duration of
the experiment. This calculation can be viewed as an
approximation to the integral value for each individual's
chimaerism, and by virtue of this it distinguishes between
individuals in which equal maxima in chimaerism were
attained but in which the rates at which chimaerism
increased were highly disparate.
All mice were regularly examined throughout the duration
of the experiments, frequently more than 100 weeks, for
palpably enlarged organs or signs of becoming moribund, at
which time they were killed. Following post-mortem
examination, mice with grossly enlarged lymphoid organs
were deemed tumour-positive. It was confirmed, as
previously reported (Wallis et al., 1984), that the spleens of
tumour-bearing mice were grossly enlarged without
exception, whereas the extent of gross involvement of other
lymphoid organs was rather more variable from individual to
individual. Enlarged spleens were routinely tested for
transplantable cells by i.v. injection of 25 x 106 spleen cells in
suspension into further CBA/Ca recipients; the spleens were
deemed to have transplantable cells if tumours arose in the
secondary recipients within 6 months ofinjection.
Lymphoid tissue from post-mortem examination was
preserved in Bouin's fluid in preparation for paraffin
sectioning and histopathological evaluation.
Results
Tumour induction after transfer ofsyngeneic spleen cellsfrom
one individual to another
In experiment A, each of 36 individual young CBA/Ca
recipients was injected with 50 x 106 spleen cells from one of
26 aged or 10 young adult CBA/T6T6 syngeneic donor mice.
The mean percentages of donor T-cells over the duration of
the experiment have been calculated for each of the 36
recipients, and are plotted in Figure la. These percentages
were highly disparate between individuals but were usually
greater in the recipients of cells from aged donors than from
young (t=2.416; P<0.05). The variability is exemplified in
Figure lb, in which the time courses of chimaerism in four
individual recipients have been plotted. All three recipients
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Figure 1 (a) Mean percent donor cells (see text) scored in PHA-
stimulated cultures of peripheral blood lymphocytes from
individual mice injected i.v. with 5 x 10' spleen cells from
individual old (O0) or young (AA) syngeneic donors. Mice
represented by open symbols developed tumour, those with
closed symbols did not; (b) Percent donor cells scored in PHA-
stimulated cultures of peripheral blood lymphocytes of 3 mice
from the same experiment injected with cells from old donors
(A 0 El) and one (0) injected with cells from a young donor.380 M.P. BRITTLE et al.
of cells from the aged donors developed transplantable
tumours. Although in the experiment as a whole mice which
subsequently developed tumours tended to have a higher
T-cell chimaerism than those which did not, this was not
statistically significant either in a Student's t test (t= 1.944)
or a Wilcoxon rank test (T= 126). Of the mice injected with
cells from old donors 54% developed tumours compared
with only 10% of the recipients of young cells (X2=4.051;
P<0.05). The tumour incidence and latent period were very
similar to those reported previously (Wallis et al., 1984) as
shown in Table I, experiments A and B.
Cytological, histological andphenotypic analysis of
transplantable tumours
Of the 14 tumours that were induced in experiment A in the
recipients of old cells, all proved transplantable when
injected i.v. into secondary hosts. Nine of these trans-
plantable tumours were examined cytologically and all had
cells with abnormal karyotypes bearing 2 or more T6 marker
chromosomes. This confirmed the donor origin of these
tumours.
A comparative histological examination of lymphoid
organs taken post-mortem in experiment A from 6 tumour-
bearing recipients of cells from aged donors and from 6
macroscopically tumour-free recipients, including 2 recipients
of cells from young donors, confirmed that enlarged organs
of tumour-bearing mice were packed with a structureless
mass of pale-staining reticulum cells characterised by their
pronounced nuclear pleiomorphy and abundant cytoplasm.
They were thus classifiable as RCN-B (Dunn & Deringer,
1968). In addition, however, a spectrum of lymphoid
pathologies ranging from low-grade follicular-type hyper-
plasia to substantial organ replacement by lymphomatous
infiltrate were discernible even in the 6 recipients that had
macroscopically normal lymphoid organs. It is likely,
therefore, that the tumour incidences shown in Table I are
underestimates.
Some of the tumours from experiments A and B were
included in a phenotypic analysis (Table II). Tumours
contained very few detectable surface Ig-bearing cells. The
proportion of cells expressing Thyl.2 was variable and
usually low, while that expressing class II products was
variable but usually high. These observations are consistent
with prior findings (Brittle et al., 1985a).
Tumour induction after injection ofpooled spleen cell
suspensions
Variability in outcome between recipients appeared to be the
rule when cells from individual spleens were injected. The
consequences of injecting cells from a pool of several spleens
were examined to see whether a 'dominant' donor cell
population might prevail in all recipients. In experiment C,
15 mice were injected with cells from a pool of 14 old
spleens. Not all recipients developed tumour. However, all
showed strikingly similar degrees of chimaerism: the mean
per cent donor cells for individual mice in serial bleedings
ranged between 39% and 49% (Figure 2a). This is
exemplified in Figure 2b which shows the results from 3
representative mice, 2 of which developed tumour and 1
which did not. Overall, 73% of the mice developed tumours,
with a mean latency of 87+ 13 weeks (Table I).
In a further experiment to examine the relationship
between donor T-cell chimaerism and gross changes in the
spleen, groups of mice which had been injected with 50
million cells from a pool of either old or young spleens
were killed at various times and their spleens weighed. The
ratio of the mean spleen weights in recipients of old
cells:recipients of young cells is plotted in Figure 3. There
appeared an early and sustained increase in spleen weights in
mice injected with cells from old donors, which was not
observed in recipients of young cells. The difference was
significant at all times (P<0.05 or less). In contrast the
donor T-cell chimaerism assessed in a group of mice which
received cells from the same pool of old spleens (Figure 3)
did not even start to increase until after 22 weeks, by which
time spleen weights had already increased by 50%. In a
parallel experiment it was found that the proportion of T
(Thyl-positive) cells was 33.5+8.5% in mice with enlarged
spleens (>1.96 x s.d. above the mean spleen weight in
recipients of young spleen cells). This was not significantly
different from the proportion in spleens of recipients of
young spleen cells (29.4+3.7%) (t= 1.412, P>0.1).
Dose response relationship
The effect of injecting graded numbers of spleen cells from
syngeneic old donors was investigated. Figure 4 shows that
donor T-cell chimaerism increased with increasing sizes of
inocula. Notably, however, even when as few as 1 x 106 cells
were injected, there was still a discernible increase in T-cell
Table I Tumour incidence and latent period of tumour induction in CBA mice injected i.v. with cells from
young or old syngeneic donors. In experiments B and G mice received all the cells from an individual spleen.
(Experiment B shows results from a previously published experiment - Wallis et al., 1984)
No. ofmice with % tumour Latent period
Exp. Cells injected tumour/total incidence (weeks)(±s.d.)
A 5 x 107 old spleen (indiv.) 14/26 54 76+20
5 x 107 young spleen (indiv.) 1/10 10 106
B old spleen (indiv.) 7/10 70 79+24
young spleen (indiv.) 1/5 20 125
C S X 107 old spleen (pooled) 11/15 73 87+ 13
5 x 107 young spleen (pooled) 0/4 0
D 108 old spleen (5 pools of 4) 5/5 100 75+ 16
5 x 107 old spleen (same pools) 5/5 100 70+ 8
107 old spleen (same pools) 3/5 60 89+37
106 old spleen (same pools) 3/5 60 63+ 2
E 108 old spleen - Pool I 4/5 80 77+ 15
2 x 107 T-cells - Pool I 2/10 20 88+ 10
108 old spleen - Pool II 5/5 100 105+16
2 x 107 T-cells - Pool II 2/8 25 93+ 9
F 5 x 107 old spleen (6 pools of 2) 5/6 83 79+30
3-7 x 106 old spleen (same pools) 3/6 50 77+29
3-7 x 101 low density cells (same pools) 4/6 67 76+32
G spleen from old T-cell deprived mice (indiv.) 1/10 10 108INDUCED RETICULUM CELL NEOPLASIA IN MICE 381
Table II Percentage of tumour cells positive for
cell surface antigens
Percentage positive cells
Exp. Tumour Ia Thyl.2 sIg
A G2 17 30 nd
R2 25 nd <1
B P 87 11 5
B S 94 nd <1
B G 20 20 <1
B L 31 25 2
B K 69 18 2
B M 88 40 <1
B V 16 23 nd
I Bi 57 24 3
I Fl 74 64 <1
I F2 73 49 <1
I F4 74 57 <1
0 50
Time (weeks) after injection
Figure 2 (a) Mean percent donor cells (see text) scored in PHA-
stimulated cultures of peripheral blood lymphocytes of individual
mice which had been injected with 5 x 107 pooled spleen cells
from old (O0) or young (A) syngeneic donors. Mice
represented by open symbols developed tumour, those with
closed symbols did not; (b) Percent donor cells scored in PHA-
stimulated cultures of 3 mice from the same experiment which
had been injected with cells from old donors. Two mice (OA)
developed tumour; one did not (-).
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Figure 3 Mean percent donor cells (0) (±s.d.) scored in PHA-
stimulated cultures of peripheral blood lymphocytes from mice
injected i.v. with 5 x 107 pooled spleen cells from old syngeneic
donors. Ratio of mean spleen weights (A) of mice from the same
experiment injected with pooled spleen cells from old or young
syngeneic donors. There were 5 mice/group.
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Figure 4 Mean percent donor cells scored in PHA-stimulated
cultures of peripheral blood lymphocytes of mice (5/group)
injected i.v. with spleen cells from old syngeneic donors. Five
pools of cells were prepared. Each pool provided cells for 4 mice
at the following doses: * =108; 0=5 x 107; A = 107; A = 106.
chimaerism and tumours appeared in a proportion of the
recipients (Experiment D, Table I).
Injection ofseparated cellpopulations
As the evidence suggested that two separate donor
populations were involved in the events following injection
of cells from aged mice into young, namely T-cells and
accessory cells, the effect of injecting populations enriched
for one or other cell type was investigated.
In Experiment E, mice were injected with 20 x 106 spleen
cells enriched for T lymphocytes. Control mice received
100 x 106 unseparated cells from the same spleen cell pool,
containing approximately the same number of T-cells
without being depleted of accessory cells (see Materials and
methods). Four of the total of 28 mice injected were
monitored for donor T-cell chimaerism (Figure 5): there was
no difference between the 2 mice injected with unseparated
cells, which developed tumour, and the 2 injected with
enriched T-cells, which did not. Overall (Table I, Experiment
E) the tumour incidence was 90% in mice receiving
unseparated spleen cells but only 22% in the recipients of
enriched T-cells: this difference was significant (2 =9.305;
P<0.01).
In experiment F (Table I), each of 6 mice was injected
with the low density cells prepared from one of 6 spleen cell
pools. Variation in the yields meant that between 3 and
7 x 106 cells were injected, depending upon the pool (see
Materials and methods). Control mice received either the
same number of unseparated cells from each respective pool
or 50 x 106 cells, corresponding to the starting population
from which the low density cells had been prepared. The
incidence and latency of tumours in experimental and
control groups were similar, whereas the mean percentage of
donor T-cells was only 7% in the 6 recipients of the low-
density cells compared with 22% in the control group which
received a similar number of unseparated cells. These values,
however, both represent substantial increases over the initial
levels of chimaerism of <1%, and suggest that T-cells
contaminated the low-density cell inoculum.
In Experiment G, mice were injected with spleen cells from
individual old T-cell-deprived donors which, it was reasoned,
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and the allostimulated recipients did not seem to be
necessary for tumour induction.
All the early arising tumours were transplantable. The
analysis of mitotic figures of 2 tumours from Experiment H
and 4 from Experiment I showed that all but one were of
syngeneic (T6) donor cell origin. The histological appearance
and phenotype of these tumours (Table II) corresponded
closely to those induced by injection of old spleen cells.
RCN-B induction in other mouse strains
To test the phenomenon of tumour induction in further
strains, cells from individual C57BL or DBA/2 donor mice
were injected into syngeneic recipients. The results are shown
in Table IV. Both strains developed a high incidence of
tumours. The latent period in C57BL mice was very similar
to that in CBA mice (Table I, experiment A), but tumours
arose significantly earlier in DBA/2 mice (cf. C57BL:
t=8.577, P<0.001; cf. CBA: 76 weeks (t=7.797, P<0.001).
Notably, in DBA/2 mice, there appeared to be no
requirement for an age difference between donor and
recipient for tumours to appear at high frequency. Both
C57BL and DBA/2 tumours had histological characteristics
80 of RCN-B.
Time (weeks) after injection
Figure 5 Percent donor cells scored in PHA-stimulated cultures
of peripheral blood lymphocytes of 4 mice from experiment E
injected i.v. with 108 unseparated spleen cells (0) or 2 x 107
T-cells (0) from pool II derived from old syngeneic donors.
would contain a normal complement of lymphoid dendritic
accessory cells but no T-cells competent to initiate even low
levels of hyperplasia. The results are reported in Table I. A
tumour arose in only 1 of 10 recipients of these cells after
the comparatively long latent period of 108 weeks.
The effect ofantigen-induced lymphoproliferation
Two further experiments (H and I) were set up to investigate
whether accessory cell neoplasia could be promoted by
providing an extrinsic antigenic stimulus to T lymphocytes,
namely a host-versus-graft alloreaction. Young CBA adult
mice received 5 x 106 pooled chromosomally-marked spleen
cells from either old or young syngeneic donors; some
mice were further injected at 2 week intervals with
(CBA x C57BL)F1 spleen cells to stimulate anti-C57BL (graft
haplotype) alloreactivity. (Table III).
RCN-B arose remarkably early in the allostimulated
groups. The mean latency in tumour appearance was 15
weeks in the first experiment and 21 in the second. This
compares with a norm of - 70 weeks in previous
experiments (Table I) in which mice did not receive
allostimulation. A high incidence of tumours was only
observed in mice which had received an inoculum of
syngeneic cells prior to allostimulation but, in contrast to
previous experiments, an age difference between the donor
Discussion
This paper confirms our previously published observation
(Wallis et al., 1984) that following the transfer of cells from
aged (>75 week) CBA strain mice to young adult syngeneic
recipients there is usually a steady increase in the proportion
of donor T-cells within the recipient beginning several
months after injection. Eventually, in most injected mice,
RCN-B tumours of donor origin also arise.
There was substantial variability in the magnitude and
kinetics of the increase in donor T-cell chimaerism when
spleen cells from individual donors were injected into
individual recipients. However, when spleen cells from a
common pool were injected, the outcome was very similar in
each host. A simple explanation for this is that one
particular set or clone of T-cells was competitively dominant
over all others within the pool; an experiment in progress, in
which T-cells derived from one of two pools of old donor
cells eventually predominated in all recipients, supports this
contention. While these findings suggested that the recipient
hosts were essentially permissive with respect to donor T-cell
proliferation, it was clear that not all individuals developed
tumour. This implies that host factors actually modulated
tumour development.
Following the injection of donor cells that had been
incubated on nylon wool, thereby bringing about an
enrichment for T-cells and a simultaneous depletion of
accessory cells, donor T-cell proliferation still occurred and,
moreover, was indistinguishable from that following the
injection of unseparated spleen cells. However, the incidence
Table III Effect of semiallogeneic (host-versus-graft) stimulation on tumour
induction in CBA mice injected with 5 x 106 syngeneic donor cells. The antigenic
stimulation was 1 x 107 (CBA x C57BL)F1 spleen cells injected at 2 week intervals
Experiment H Experiment I
No. ofmice Latent No. ofmice Latent
Antigenic with period with period
Cells injected stimulation tumour/total (weeks) tumour/total (weeks)
Old spleen - 0/4
+ 1/4 16
Young spleen - 0/8 1/12 20
+ 8/8 15 6/12 21
None + 0/4
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Table IV Tumour incidence and latent period of tumour induction
in DBA/2 and C57BL mice injected i.v. with spleen cells from young
or old syngeneic donors. Each mouse received the cells from an
individual spleen
Age of No. ofmice with tumour Latent period
Exp. Strain donor tumour/total incidence (weeks) +s.d.
J DBA/2 old 10/11 91 23+ 9
young 4/4 100 41+31
K C57BL old 10/12 83 69+ 15
young 1/5 20 54
of tumours was reduced to a quarter of the control value.
Therefore, in most individuals, the proliferation proceeded in
the absence of the target cells for tumorigenesis, which
argues against the hypothesis that they themselves directly
stimulated the donor T-cells. Perhaps the T-cells were
immunologically stimulated by unique antigenic epitopes that
characterise each individual, but this of course does not
explain how the proliferation appeared selective for cells
from aged donors. It may be analogous to the age-dependent
graft-versus-host reactivity described by Gozes et al. (1978)
which was manifest as lymph node enlargement following
injection of T-cells from aged syngeneic donors. This did not
occur when young donor cells were injected into aged
recipients. Furthermore, enlargement was not abolished by
prior irradiation of the recipient animals, which indicates
that young host cells were not contributing to the node
hyperplasia. No comprehensive explanation for the
phenomenon was advanced. An in vitro parallel to this exists
in the work of Callard et al. (1979) who demonstrated mixed
lymphocyte responses between spleen cells of young and old
mice of the same strain, which were slightly greater when old
cells were reacting against young than vice versa. They attri-
buted this to novel antigenic determinants on the surface of
lymphocytes from old mice. Presumably, these could have
heightened their sensitivity to self antigens.
While it is clear that development of high levels of donor
T-cell chimaerism did not inevitably lead to the development
of tumours, the dependence of tumour development upon
T-cell chimaerism appears to be more complex. On the
one hand, some mice injected with unseparated old cells
developed tumours with little or no increase in T-cell
chimaerism, suggesting that it was unimportant. On the
other hand, it emerged that the selective increase was itself
preceded by a splenic lymphoid hyperplasia, apparently
involving both T- and non-T-cells. This underlines the
possibility that T lymphocyte proliferation per se, eventually
signalled in most experimental hosts as a selective donor T-
cell increase, is the underlying event predisposing to tumour
induction.
This view is consistent with the result from the other
experiments. Firstly, donor cells from aged T-cell-deprived
mice failed to produce tumours. Because these mice, as far as
is known, contained a normal complement of target cells, the
simplest explanation for this is that they contained no T-cells
capable of proliferation after transfer. Secondly, donor cells
from young mice did not give rise to tumours unless
recipients were repeatedly stimulated by Fl spleen cells.
Presumably, this was because the immunological milieu of
the host-versus-graft proliferative T-cell response provided
intense stimulation for RCN-B development similar to that
attributed to aged T-cell proliferation in the earlier
experiments. It is implicit in this argument that the failure of,
tumour induction when young donor cells were injected into
unstimulated hosts was not actually due to the absence of
target cells but was because there was no T-cell proliferation.
At present, the nature of the tumour-stimulating factor(s)
associated with T-cell proliferation is unknown.
Tumour induction remained remarkably selective for
donor target cells throughout this work, even after injection
of only a few million spleen cells, corresponding to, perhaps,
only 1-2% of the host complement of such cells. This could
be because, following i.v. injection, target accessory celje
encounter the new environment of the host or because the"y
fail to 'home' to their normal site. Either event could lead to
altered or defective homeostatic regulation predisposing to
malignant transformation. That ectopic relocation as a result
of i.v. injection may be sufficient to increase their chance of
transformation is supported by preliminary experiments in
which a high incidence of tumours arose in allostimulated
mice previously injected with autologous spleen cells.
Support for the suggestion that target cells may not regain a
physiologically normal 'niche' after transfer is given by
studies showing that accessory cells lack the recirculatory
capacity clearly proven for T and B lymphocytes. It is
known, for example, that accessory cells are found only in
trace numbers in the blood (van Voorhis et al., 1983).
Although abundant in the afferent lymph of stimulated
nodes (Knight et al., 1982) they do not as a rule traverse the
node: the ratio of cellular entry to exit is 10:1 in the rat
(Drayson et al., 1985).
The hypothesis that ectopic redistribution of accessory
cells predisposes to malignant change can explain RCN-B
induction not only in the CBA strain, but also in C57BL
and DBA/2 strains. However, further experimentation in the
two latter strains using syngeneic donor and host pairs that
are readily distinguishable by chromosomal or other markers
is necessary to confirm that the induced tumours are actually
of donor origin, and to determine whether there is a
preceding expansion of the donor T-cell population.
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